Price $1.35 |
Market Cap
150M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.36
|
P/S
2.61
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-121.6K
|
FCF
-1.2
|
|
Op. Margin
-104.60%
|
Net Margin
-126.70%
|
ROE
-76.70%
|
ROI
-
|
|
ROA
-34.00%
|
EPS Growth
19.00%
|
Current Ratio
7.7
|
Debt/Equity
105.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $8.93 | - | - | 10.87B | Strong Buy |
| Accuray Incorporated (ARAY) | $4.43 | - | - | 358.8M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.54 | - | - | 110.9M | Strong Buy |
| ConforMIS Inc (CFMS) | $1.20 | - | - | 247.3M | Strong Buy |
| Lantheus Holdings Inc (LNTH) | $22.54 | - | - | 1.74B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
